IDEAYA Biosciences Inc (IDYA)
40.51
-1.02
(-2.46%)
USD |
NASDAQ |
May 17, 16:00
40.51
0.00 (0.00%)
After-Hours: 20:00
IDEAYA Biosciences Cash from Financing (TTM): 708.90M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 708.90M |
| December 31, 2023 | 362.72M |
| September 30, 2023 | 222.15M |
| June 30, 2023 | 290.01M |
| March 31, 2023 | 99.44M |
| December 31, 2022 | 97.16M |
| September 30, 2022 | 97.53M |
| June 30, 2022 | 88.61M |
| March 31, 2022 | 104.10M |
| December 31, 2021 | 145.45M |
| September 30, 2021 | 151.72M |
| Date | Value |
|---|---|
| June 30, 2021 | 92.01M |
| March 31, 2021 | 170.72M |
| December 31, 2020 | 128.75M |
| September 30, 2020 | 121.84M |
| June 30, 2020 | 94.50M |
| March 31, 2020 | 51.47M |
| December 31, 2019 | 50.61M |
| September 30, 2019 | 50.50M |
| June 30, 2019 | 50.81M |
| March 31, 2019 | -0.868M |
| December 31, 2018 | 105.38M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
50.50M
Minimum
Sep 2019
708.90M
Maximum
Mar 2024
158.95M
Average
101.77M
Median
Cash from Financing (TTM) Benchmarks
| Merck & Co Inc | -5.57B |
| Pfizer Inc | 23.91B |
| Geron Corp | 228.77M |
| Verastem Inc | 90.99M |
| Karyopharm Therapeutics Inc | -- |